| 期 |
标题 |
文件 |
| 卷 17, 编号 4 (2020) |
Contrast-associated acute kidney injury in patients with arterial hypertension and coronary artery disease and its long-term prognosis |
(Rus)
|
|
Mironova O., Fomin V.
|
| 卷 17, 编号 3 (2020) |
Contrast-associated acute kidney injury in patients with arterial hypertension and stable coronary artery disease |
(Rus)
|
|
Mironova O., Fomin V.
|
| 卷 13, 编号 4 (2016) |
The control of blood pressure level as the prevention of cognitive impairment |
(Rus)
|
|
Melnik M., Afonicheva I., Kazyulin A.
|
| 卷 15, 编号 4 (2018) |
Polypill" conception in modern cardiology |
(Rus)
|
|
Chazova I., Aksenova A., Zhernakova Y.
|
| 卷 2, 编号 2 (2005) |
Korotkiy put' k zavetnoy tseli – ko-renitek dlya patsienta s AG |
|
|
Chazova I., Ratova L.
|
| 卷 10, 编号 3 (2013) |
Korrektsiya dislipidemiy pri soputstvuyushchey arterial'noy gipertonii s pozitsiy obnovlennoy paradigmy serdechno-sosudistogo riska |
|
|
Gurevich V.
|
| 卷 3, 编号 2 (2006) |
Korrektsiya disfunktsii endoteliya pri arterial'noy gipertonii: fokus na beta -blokatory |
|
|
Ostroumova O., Dubinskaya R., Zhukova O.
|
| 卷 5, 编号 3 (2008) |
Korrektsiya narusheniy lipidnogo obmena u bol'nykh sakharnym diabetom tipa 2 |
|
|
Kozlov S., Lyakishev A.
|
| 卷 7, 编号 2 (2010) |
Koeffitsient anizotropii eritrotsitov u molodykh muzhchin s arterial'noy gipertoniey 1-y stepeni: vzaimosvyaz' s disfunktsiey endoteliya i drugimi faktorami riska serdechno-sosudistykh oslozhneniy |
|
|
Zairova A., Rogoza A., Oshchepkova E., Titov V.
|
| 卷 17, 编号 2 (2020) |
PAH: beyond the idiopathic form of disease |
(Rus)
|
|
Martynyuk T., Shmalts A., Klimenko A.
|
| 卷 13, 编号 2 (2016) |
Demographic and clinical differences between idiopathic and scleroderma-related pulmonary arterial hypertension: Russian National Registry analysis |
(Rus)
|
|
Yudkina N., Valeeva E., Taran I., Nikolaeva E., Paramonov V., Kurmukov I., Valieva Z., Arkhipova O., Martynyuk T., Volkov A., Nasonov E., Chazova I.
|
| 卷 10, 编号 2 (2013) |
Legochnaya arterial'naya gipertenziya: na puti ot ratsional'noy diagnostiki k vyboru effektivnoy lekarstvennoy terapii |
|
|
Chazova I., Martynyuk T.
|
| 卷 17, 编号 2 (2020) |
Pulmonary hypertension or cardiology aerobatics |
(Rus)
|
|
Chazova I., Martynyuk T., Danilov N.
|
| 卷 1, 编号 1 (2004) |
Legochnaya gipertenziya pri khronicheskoy obstruktivnoy bolezni legkikh |
|
|
Avdeev S.
|
| 卷 17, 编号 2 (2020) |
Pulmonary hypertension in patients with hemodynamically significant atherosclerotic lesion of a common carotid artery: new pathophysiological mechanisms of the disease |
(Rus)
|
|
Markov M., Davydova M., Usachev D., Lukshin V., Balakhonova T., Rodnenkov O., Martynyuk T.
|
| 卷 16, 编号 2 (2019) |
Drug-induced arterial hypertension |
(Rus)
|
|
Ostroumova O., Kulikova M.
|
| 卷 9, 编号 2 (2012) |
Lerkanidipin - blokator kal'tsievykh kanalov III pokoleniya |
|
|
Kirichenko A.
|
| 卷 7, 编号 1 (2010) |
Lerkanidipin - novyy antagonist kal'tsiya III pokoleniya dlya lecheniya arterial'noy gipertenzii (referat) |
|
|
Gasser R., Köppel H., Klein W.
|
| 卷 10, 编号 4 (2013) |
Lercanidipine as a calcium antagonist of the third generation: a review of effectiveness in the hypertension treatment |
|
|
Zadionchenko V., Shekhyan G., Yalymov A., Varentsov S.
|
| 卷 4, 编号 1 (2007) |
Lerkanidipin – novyy blokator kal'tsievykh kanalov: effektivnost' primeneniya u bol'nykh arterial'noy gipertoniey |
|
|
Chikhladze N., Chazova I.
|
| 卷 10, 编号 4 (2013) |
Summer School on hypertension 2013 in Portugal |
|
|
Arkhipova O., Starostin I.
|
| 卷 7, 编号 4 (2010) |
Letnyaya shkola po arterial'noy gipertonii 2010 g. v Khorvatii |
|
|
Makhiyanova E.
|
| 卷 8, 编号 4 (2011) |
Letnyaya shkola po arterial'noy gipertonii 2011 g. v Barselone (Ispaniya) |
|
|
Dolgusheva Y., Kobal' E.
|
| 卷 9, 编号 4 (2012) |
The 2012 hypertension summer school in Dublin (Ireland) |
|
|
Blinova N., Elfimova E.
|
| 卷 12, 编号 3 (2015) |
Treatment of hypertension in overweight patients |
(Rus)
|
|
Kukes V., Anikin G., Andreevskaya E., Ashurkova E.
|
| 卷 4, 编号 2 (2007) |
Lechenie arterial'noy gipertenzii u pozhilykh bol'nykh |
|
|
Repin A., Sergienko T., Karpov R.
|
| 卷 10, 编号 1 (2013) |
Hypertension treatment: Is there a place for b-adrenoblockers? |
|
|
Minushkina L.
|
| 卷 5, 编号 1 (2008) |
Lechenie arterial'noy gipertonii u bol'nykh s metabolicheskim sindromom |
|
|
Chazova I., Ratova L.
|
| 卷 5, 编号 4 (2008) |
Lechenie arterial'noy gipertonii: sravnenie klinicheskoyi ekonomicheskoy effektivnosti original'nykh i genericheskikh preparatov |
|
|
Ostroumova O., Bondarets O., Shorikova E.
|
| 卷 4, 编号 2 (2007) |
Lechenie dislipidemii kak vazhnyy faktor profilaktiki ateroskleroza i ego oslozhneniy |
|
|
Kukharchuk V.
|
| 卷 3, 编号 1 (2006) |
Lechenie patsienta s arterial'noy gipertenziey i gipertrofiey levogo zheludochka |
|
|
Chazova I., Ratova L., Ataullakhanova D.
|
| 卷 7, 编号 3 (2010) |
Lozartan v praktike terapevta |
|
|
Stryuk R.
|
| 卷 11, 编号 4 (2014) |
Local rigidity of the walls of the carotid artery at the site of formation of atherosclerotic plaques in patients with arterial hypertension |
(Rus)
|
|
Vakhovskaya T., Tripoten M., Pogorelova O., Balakhonova T., Loukianov M., Boytsov S.
|
| 卷 13, 编号 4 (2016) |
Coagulation markers in patients with obstructive sleep apnea syndrome and effects of continuous positive airway pressure |
(Rus)
|
|
Bugaev T., Elfimova E., Ageeva N., Dobrovolskiy A., Litvin A.
|
| 卷 14, 编号 4 (2017) |
Markers of early target-organ brain damage in essential arterial hypertension: the search continues. Possibilities of diffusion tensor magnetic resonance imaging |
(Rus)
|
|
Parfenov V., Ostroumova T., Ostroumova O., Perepelova E., Perepelov V.
|
| 卷 18, 编号 2 (2021) |
Drug therapy of arterial hypertension: assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project |
(Rus)
|
|
Bontsevich R., Vovk Y., Gavrilova A., Kirichenko A., Krotkova I., Kosmacheva E., Kompaniets O., Prozorova G., Nevzorova V., Martynenko I., Ketova G., Barysheva V., Maksimov M., Osipova O.
|
| 卷 9, 编号 2 (2012) |
Mediko-sotsial'nye aspekty priverzhennosti lecheniyu arterial'noy gipertenzii u rabotnikov promyshlennykh predpriyatiy |
|
|
Indukaeva E., Makarov S., Ogarkov M., Artamonova G.
|
| 卷 12, 编号 1 (2015) |
Medical and social risk factors for arterial hypertension in coal miners |
(Rus)
|
|
Indukaeva E., Makarov S., Ogarkov M.
|
| 卷 13, 编号 1 (2016) |
The role of b-blockers in treatment of hypertension, according to Russian and European experts |
(Rus)
|
|
Ostroumova O., Fomina V., Shchukina G., Smoliarchuk E.
|
| 卷 15, 编号 4 (2018) |
The role of b-blockers in the new revision of the 2018 European guidelines for the diagnosis and treatment of arterial hypertension in the patients with comorbidities |
(Rus)
|
|
Ostroumova O., Kochetkov A.
|
| 卷 6, 编号 1 (2009) |
The place of b-blocker and diuretic in the Russian guidelines of arterial hypertension 2008 |
|
|
Chazova I., Ratova L., Chazova I., Ratova L.
|
| 卷 6, 编号 3 (2009) |
Mesto agonistov imidazolinovykh retseptorov v lechenii arterial'noy gipertenzii: rezul'taty issledovaniya MERSY v Rossii |
|
|
Chazova I., Mychka V., Ratova L.
|
| 卷 11, 编号 1 (2014) |
Place of angiotensin receptor blockers in antihypertensive therapy |
(Rus)
|
|
Martynov A., Urlaeva I., Akatova E., Nikolin O.
|
| 卷 10, 编号 4 (2013) |
Place of angiotensin receptor blockers in the treatment of hypertension according to the latest recommendations of the 2013 European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) for the treatment of hypertension |
|
|
Chukaeva I., Solovieva M., Litvinova S.
|
| 卷 10, 编号 2 (2013) |
The place of Indapamide retard in the treatment of patients with left ventricular dysfunction and preserved systolic function in the presence of arterial hypertension |
|
|
Tereshchenko S., Zhirov I.
|
| 卷 15, 编号 1 (2018) |
The place of intervention methods of treatment of patients with resistant hypertension in clinical practice |
(Rus)
|
|
Agaeva R., Danilov N., Sagaydak O., Chazova I.
|
| 卷 5, 编号 4 (2008) |
Mesto nizkodozovykh fiksirovannykh kombinatsiy antigipertenzivnykh preparatov u patsientov s arterial'noy gipertoniey |
|
|
Ratova L., Chazova I.
|
| 卷 8, 编号 2 (2011) |
Mesto sartanov v lecheniiarterial'noy gipertenzii.Aktsent na olmesartan |
|
|
Morozova T., Gurova A.
|
| 卷 17, 编号 4 (2020) |
The place of fixed antihypertensive drugs in modern therapy of arterial hypertension |
(Rus)
|
|
Pinchuk T., Orlova N.
|
| 卷 6, 编号 1 (2009) |
Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial |
|
|
Giuseppe Derosa -., Arrigo FG Cicero -., Angela D'Angelo -., Elena Fogari -., Sibilla Salvadeo -., Alessia Gravina -., Ilaria Ferrari -., Raffaella Fassi -., Roberto Fogari -.
|
| 卷 5, 编号 4 (2008) |
Metabolicheskie i antioksidantnye effekty nebivolola pri lechenii bol'nykh arterial'noy gipertenziey |
|
|
Napalkov D., Golovenko E.
|
| 卷 9, 编号 2 (2012) |
Metabolicheskie i organoprotektivnye effekty kombinatsii amlodipina i atorvastatina u bol'nykh s metabolicheskim sindromom |
|
|
Blinova N., Saidova M., Tishina E., Chazova I.
|
| 卷 5, 编号 2 (2008) |
Metabolicheskiy sindrom - mif ili real'nost'? |
|
|
Mychka V., Chazova I.
|
| 卷 17, 编号 3 (2020) |
Speckle-tracking echocardiography in 3D mode in assessing the deformation of the myocardium and identifying subclinical cardiotoxicity during chemotherapy in breast cancer patients with arterial hypertension |
(Rus)
|
|
Avalyan A., Saidova M., Oshchepkova E., Chazova I.
|
| 卷 11, 编号 4 (2014) |
Methods of sympathetic activity evaluation in patients with systemic refractory hypertension |
(Rus)
|
|
Grigin V., Danilov N., Sagaydak O., Shelkova G., Chazova I.
|
| 卷 11, 编号 2 (2014) |
The mechanisms of developmentcardiovascular disease and type 2 diabetes: the role of insulin resistance, hyperinsulinemia and hypoadiponektinemia. Treatment and management |
(Rus)
|
|
Shishkova V.
|
| 卷 13, 编号 1 (2016) |
MicroRNA in the diagnosis of chronic heart failure: state of the problem and the results of a pilot study |
(Rus)
|
|
Zhirov I., Kochetov A., Zaseeva A., Liang O., Skvortsov A., Abramov A., Gimadiev R., Masenko V., Tereshchenko S.
|
| 卷 14, 编号 1 (2017) |
Mitral insufficiency: systematization, conservative and surgical treatment |
(Rus)
|
|
Cherepanova E., Gurevich M.
|
| 卷 12, 编号 3 (2015) |
Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension |
(Rus)
|
|
Chazova I., Karpov Y., Chukaeva I., Kislyak O., Zhernakova Y., Martynuk T., Litvin A.
|
| 卷 10, 编号 2 (2013) |
Mnenie ekspertov Rossiyskogo meditsinskogo obshchestva po arterial'noy gipertonii: znachenie fiksirovannykh kombinatsiy v uluchshenii kontrolya arterial'nogo davleniya |
|
|
- -.
|
| 卷 7, 编号 1 (2010) |
Mnogolikie sartany |
|
|
Polos'yants O., Silina E.
|
| 卷 9, 编号 2 (2012) |
Mochevaya kislota i funktsiya endoteliya mikrotsirkulyatornogo rusla u bol'nykh na rannikh stadiyakh arterial'noy gipertonii |
|
|
Atyunina I., Oshchepkova E., Fedorovich A., Dmitriev V., Gushchina O., Titov V., Rogoza A.
|
| 卷 8, 编号 3 (2011) |
Mochevaya kislotai serdechno-sosudistye zabolevaniya:novyy S-reaktivnyy belok? |
|
|
Gilyarevskiy S., Kuz'mina I., Kelekhsaev K.
|
| 卷 9, 编号 4 (2012) |
The availability of a home tonometer as a factor that increases therapy compliance in outpatients with arterial hypertension |
|
|
Smirnova M., Tsygareishvili E., Ageyev F., Svirida O., Kuzmina A., Fofanova T.
|
| 卷 11, 编号 3 (2014) |
Nebivolol for treatment patients with arterial hypertension |
(Rus)
|
|
Mikheeva O., Komisarenko I.
|
| 卷 16, 编号 4 (2019) |
Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy |
(Rus)
|
|
Oshchepkova E., Avalyan A., Rogoza A., Gorieva S., Saidova M., Chazova I.
|
| 卷 18, 编号 1 (2021) |
Uncontrolled arterial hypertension: main causes, features of pathogenesis and approaches to treatment |
(Rus)
|
|
Denisova A., Solntseva T., Sivakova O., Chazova I.
|
| 卷 9, 编号 3 (2012) |
Nemedikamentoznye metody lecheniya patsientov s arterial'noy gipertenziey i bronkhoobstruktivnoy patologiey |
|
|
Zykov K., Ratova L., Agapova O., Chazova I.
|
| 卷 1, 编号 2 (2004) |
Nefroprotektivnyy effekt antigipertenzivnoy terapii: issledovanie IRIS |
|
|
Ratova L., Chazova I.
|
| 卷 8, 编号 1 (2011) |
Nefroprotektivnyy effekt fiksirovannoy kombinatsii lizinoprila i amlodipina u bol'nykh sakharnym diabetom i arterial'noygipertenziey. |
|
|
Protasov K., Fedorishina O., Dzizinskiy A., Antonenko N., Boronova V., Mamonova T., Tsareva L., Panteleeva E.
|
| 卷 2, 编号 1 (2005) |
Nefroprotektsiya v lechenii bol'nykh arterial'noy gipertoniey (rezul'taty issledovaniya IRIS) |
|
|
Chazova I., Ratova L., Kolos I., Kotkina T., Martsevich S., Moiseeva O., Kozyreva M., Dmitrieva N., Semenova Y., Andreeva G., Voronina V., Lukina Y., Ivanenkova P., Serazhim A., Fel'dsherova N.
|
| 卷 13, 编号 2 (2016) |
Nephroprotective in patients with metabolic syndrome: approaches to the appointment of antihypertensive drugs |
(Rus)
|
|
Ostroumova O., Zykova A., Maksimov M.
|
| 卷 15, 编号 3 (2018) |
Physical inactivity as a risk factor for cardiovascular morbidity and mortality |
(Rus)
|
|
Krivoshapova K., Tsygankova D., Barbarash O.
|
| 卷 14, 编号 2 (2017) |
A new fixed combination of perindopril, indapamide and amlodipine. "Three in one" is the way to improve the results of arterial hypertension treatment |
(Rus)
|
|
Temnikova E.
|
| 卷 10, 编号 3 (2013) |
Novoe pokolenie blokatorov retseptorov angiotenzina |
|
|
Podzolkov V., Tarzimanova A.
|
| 卷 3, 编号 2 (2006) |
Novye vozmozhnosti v lechenii bol'nykh s metabolicheskim sindromom (rezul'taty issledovaniya ALMAZ) |
|
|
Chazova I., Mychka V.
|
| 卷 5, 编号 3 (2008) |
Novye vozmozhnosti v lechenii serdechno-sosudistykh zabolevaniy: rezul'taty issledovaniya ONTARGET |
|
|
Chazova I.
|
| 卷 5, 编号 4 (2008) |
Novye vozmozhnosti v strategii lecheniya bol'nykh s idiopaticheskoylegochnoy gipertenziey: antagonist retseptorov endotelina bozentan |
|
|
Martynyuk T., Chazova I.
|
| 卷 17, 编号 2 (2020) |
New opportunities for reducing cardiovascular risk in the Russian Federation |
(Rus)
|
|
Ostroumova O., Sergienko I., Zhernakova Y.
|
| 卷 5, 编号 2 (2008) |
Novye Evropeyskie rekomendatsii po vedeniyu patsientov s arterial'noy gipertoniey: mesto sartanov |
|
|
Chazova I.
|
| 卷 16, 编号 4 (2019) |
New approaches to the analysis of daily variability of sinus rhythm in assessing the antihypertensive effect of various drugs |
(Rus)
|
|
Sobolev A., Talabanov P., Ryabykina G., Kozhemyakina E., Oshchepkova E.
|
| 卷 8, 编号 3 (2011) |
Novye Rossiyskie rekomendatsiipo AG - prioritet kombinirovannoyterapii |
|
|
Arkhipov M., Arutyunov G., Boytsov S., Galyavich A., Karpov Y., Kobalava Z., Makolkin V., Martynov A., Nebieridze D., Nedogoda S., Ostroumova O., Oshchepkova E., Smolenskaya O., Shal'nova S., Chazova I.
|
| 卷 11, 编号 1 (2014) |
New trends in the treatment of hypertension in 2013: the renaissance of pulse pressure |
(Rus)
|
|
Ostroumova O., Galeeva N.
|
| 卷 10, 编号 1 (2013) |
The new widely discussed clinically significant aspects influence of β-blockers |
|
|
Arutyunov G.
|
| 卷 7, 编号 4 (2010) |
Novyy b1-adrenoblokator s vazodilatiruyushchim effektom Binelol®: antigipertenzivnye, mikrotsirkulyatornye i metabolicheskie effekty. |
|
|
Spasskaya M., Kulieva G., Safaryan A., Ivanishina N.
|
| 卷 14, 编号 3 (2017) |
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders |
(Rus)
|
|
Chazova I., Zhernakova Y., Blinova N., Rogoza A.
|
| 卷 3, 编号 1 (2006) |
Novyy predstavitel' klassa statinov - krestor: vozmozhnosti v lechenii bol'nykh s metabolicheskim sindromom |
|
|
Chazova I., Mychka V., Mamyrbaeva K., Masenko V., Flegontova N., Sergienko V.
|
| 卷 10, 编号 2 (2013) |
Do spirometry for patients with cardiovascular diseases? |
|
|
Nazarov B., Zykov K., Ratova L., Agapova O., Dolgusheva Y., Chazova I.
|
| 卷 9, 编号 1 (2012) |
Obzor meropriyatiya. VIII Vserossiyskiy kongress «Arterial'naya gipertoniya: ot A.L.Myasnikova do nashikh dney» |
|
|
- -.
|
| 卷 12, 编号 2 (2015) |
The recommendations review concerning the maintenance of patients with arterial hypertension: evidence and expert opinions |
(Rus)
|
|
Samorodskaya I., Boitsov S.
|
| 卷 6, 编号 4 (2009) |
Rationale for the use of sartans in patients with arterial hypertension |
|
|
Stryuk R.
|
| 卷 4, 编号 2 (2007) |
Obrazovatel'nyy Master-kurs po arterial'noy gipertonii i serdechno-sosudistomu risku |
|
|
- -.
|
| 卷 4, 编号 2 (2007) |
Obratimyy stenoz i fibromyshechnaya displaziya pochechnoy arterii v sluchae feokhromotsitomy |
|
|
Potapova G., Kazanchyan P., Veselova S., Samko A., Masenko V., Sitina V., Chazova I.
|
| 卷 8, 编号 1 (2011) |
Obrashchenie k doktoru |
|
|
- -.
|
| 卷 11, 编号 3 (2014) |
Education and self-education of the patients is an important step towards increasing patients acceptance of therapy |
(Rus)
|
|
Chazova I., Ageev F., Fofanova T., Chikhladze N., Kuznetsova M., Smirnova M., Ostrogorskaya V., Geraschenko Y.
|
| 卷 12, 编号 2 (2015) |
Restriction of caloric intake is a key to prevention of vascular ageing |
(Rus)
|
|
Orlova Y.
|
| 卷 16, 编号 1 (2019) |
Obesity and hypertension: the role of criteria |
(Rus)
|
|
Tsygankova D., Krivoshapova K., Maksimov S., Indukaeva E., Shapovalova E., Artamonova G., Barbarash O.
|
| 卷 15, 编号 3 (2018) |
Obesity as a predictor for cardiovascular disease development: role of localized fat depot |
(Rus)
|
|
Azimova M., Blinova N., Zhernakova Y., Chazova I.
|
| 卷 17, 编号 4 (2020) |
Obesity as a risk factor of contrast-induced acute kidney injury in patients with arterial hypertension and stable coronary artery disease |
(Rus)
|
|
Mironova O., Sivakova O., Fomin V.
|
| 卷 3, 编号 2 (2006) |
Opredeleno li mesto beta-adrenoblokatorov pri lechenii arterial'noy gipertonii? |
|
|
Makolkin V.
|
| 301 - 400 的 734 信息 |
<< < 1 2 3 4 5 6 7 8 > >> |
